Sysmex Corporation (SSMXY)
USD 18.76
(-0.27%)
USD 18.76
(-0.27%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 77.29 Billion JPY | 7.89% |
| 2023 | 72.65 Billion JPY | 4.44% |
| 2022 | 69.56 Billion JPY | 41.49% |
| 2021 | 49.16 Billion JPY | -9.79% |
| 2020 | 54.5 Billion JPY | -10.36% |
| 2019 | 60.79 Billion JPY | 1.42% |
| 2018 | 59.94 Billion JPY | 17.95% |
| 2017 | 50.82 Billion JPY | -16.29% |
| 2016 | 60.71 Billion JPY | 36.7% |
| 2015 | 44.41 Billion JPY | 35.11% |
| 2014 | 32.87 Billion JPY | 50.75% |
| 2013 | 21.8 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 13.13 Billion JPY | -38.65% |
| 2024 Q2 | 20.28 Billion JPY | 54.48% |
| 2024 Q3 | 19.29 Billion JPY | -4.87% |
| 2024 FY | 77.29 Billion JPY | 6.39% |
| 2024 Q4 | 24.59 Billion JPY | 27.44% |
| 2023 Q2 | 20.14 Billion JPY | 84.97% |
| 2023 FY | 72.65 Billion JPY | 4.44% |
| 2023 Q4 | 21.4 Billion JPY | 5.81% |
| 2023 Q3 | 20.22 Billion JPY | 0.42% |
| 2023 Q1 | 10.88 Billion JPY | -38.69% |
| 2022 Q3 | 17.66 Billion JPY | -8.29% |
| 2022 Q2 | 19.25 Billion JPY | 29.34% |
| 2022 FY | 69.56 Billion JPY | 41.49% |
| 2022 Q1 | 14.89 Billion JPY | -5.87% |
| 2022 Q4 | 17.76 Billion JPY | 0.56% |
| 2021 Q2 | 13.04 Billion JPY | 87.51% |
| 2021 FY | 49.16 Billion JPY | -9.79% |
| 2021 Q3 | 15.9 Billion JPY | 21.9% |
| 2021 Q1 | 6.95 Billion JPY | -51.92% |
| 2021 Q4 | 15.81 Billion JPY | -0.53% |
| 2020 Q4 | 14.47 Billion JPY | 14.69% |
| 2020 FY | 54.5 Billion JPY | -10.36% |
| 2020 Q3 | 12.61 Billion JPY | -23.64% |
| 2020 Q2 | 16.52 Billion JPY | 46.49% |
| 2020 Q1 | 11.28 Billion JPY | -40.2% |
| 2019 Q3 | 14.06 Billion JPY | -4.12% |
| 2019 FY | 60.79 Billion JPY | 1.42% |
| 2019 Q1 | 13.83 Billion JPY | -10.34% |
| 2019 Q2 | 14.67 Billion JPY | 6.07% |
| 2019 Q4 | 18.86 Billion JPY | 34.09% |
| 2018 Q3 | 16.57 Billion JPY | 6.43% |
| 2018 FY | 59.94 Billion JPY | 17.95% |
| 2018 Q1 | 12.43 Billion JPY | 4.05% |
| 2018 Q4 | 15.42 Billion JPY | -6.94% |
| 2018 Q2 | 15.57 Billion JPY | 25.27% |
| 2017 Q2 | 13.15 Billion JPY | -5.21% |
| 2017 Q3 | 12.13 Billion JPY | -7.77% |
| 2017 Q4 | 11.95 Billion JPY | -1.5% |
| 2017 FY | 50.82 Billion JPY | -16.29% |
| 2017 Q1 | 13.87 Billion JPY | -5.95% |
| 2016 FY | 60.71 Billion JPY | 36.7% |
| 2016 Q3 | 15.54 Billion JPY | 1.15% |
| 2016 Q2 | 15.37 Billion JPY | 36.13% |
| 2016 Q1 | 11.29 Billion JPY | -12.44% |
| 2016 Q4 | 14.75 Billion JPY | -5.09% |
| 2015 Q1 | 8.76 Billion JPY | -18.46% |
| 2015 Q4 | 12.89 Billion JPY | 13.0% |
| 2015 Q3 | 11.41 Billion JPY | 0.62% |
| 2015 Q2 | 11.34 Billion JPY | 29.43% |
| 2015 FY | 44.41 Billion JPY | 35.11% |
| 2014 Q2 | 8.93 Billion JPY | 86.82% |
| 2014 FY | 32.87 Billion JPY | 50.75% |
| 2014 Q4 | 10.74 Billion JPY | 27.76% |
| 2014 Q3 | 8.41 Billion JPY | -5.82% |
| 2014 Q1 | 4.78 Billion JPY | -27.69% |
| 2013 Q3 | 4.6 Billion JPY | -29.29% |
| 2013 Q2 | 6.5 Billion JPY | 0.0% |
| 2013 FY | 21.8 Billion JPY | 0.0% |
| 2013 Q4 | 6.61 Billion JPY | 43.68% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | -6639280.873% |
| Ansell Limited | 129.3 Million USD | -59681.129% |
| Ansell Limited | 129.3 Million USD | -59681.129% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 31.13 Million USD | -248138.578% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 4844177.932% |
| Psykey, Inc. | -797.5 Thousand USD | 9692465.179% |
| ConvaTec Group Plc | 262.7 Million USD | -29324.058% |
| ConvaTec Group Plc | 262.7 Million USD | -29324.058% |
| Encision Inc. | -640.78 Thousand USD | 12062998.048% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 54507539.532% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 70314845.747% |
| Innovative MedTech Inc. | -4.27 Million USD | 1808607.851% |
| LifePoint, Inc. | -7.49 Million USD | 1031382.838% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 1192954.938% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | -23423233.333% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | 62899440.874% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 16542072.873% |
| SmileDirectClub, Inc. | -241.15 Million USD | 32152.696% |
| Sector 10, Inc. | -39.84 Thousand USD | 193999196.476% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | -24085.031% |
| SheerVision, Inc. | 155.72 Thousand USD | -49636441.104% |
| United Health Products, Inc. | -2.42 Million USD | 3185583.522% |
| Vasamed, Inc. | 4.74 Million USD | -1629846.806% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 3369422.112% |
| Yubo International Biotech Limited | -1.2 Million USD | 6413601.9% |